Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Infectious Disease PHGKB

Specific PHGKB|Infectious Diseases PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last Posted: Apr 22, 2024
spot light Spotlight

Microbiome-based therapeutics
(Posted Apr 21, 2024 8AM)

From the article: "The gut microbiome plays an important part in a number of gastrointestinal conditions, including Clostridioides difficile infection and inflammatory bowel disease. Interest in modulating the gut microbiome, through prebiotics, probiotics, and natural or artificial microbiota therapeutics, has increased markedly in the past decade. Although the field has developed rapidly, it has faced reproducibility issues and encountered safety and regulatory hurdles. This two-part Series explores the development and promise of artificial microbiome therapeutics, and the current and future perspectives for microbiota therapies for treating inflammatory bowel disease. "

Adherence to the Mediterranean diet can beneficially affect the gut microbiota composition: a systematic review
(Posted Apr 19, 2024 10AM)

From the abstract: "Dietary patterns could have a notable role in shaping gut microbiota composition. Evidence confirms the positive impact of the Mediterranean diet (MD), as one of the most studied healthy dietary patterns, on the gut microbiota profile. We conducted this systematic review to investigate the results of observational studies and clinical trials regarding the possible changes in the gut microbiota composition, metabolites, and clinical outcomes following adherence to MD in healthy cases or patients suffering from metabolic disorders. "

Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates
RH Holm et al, Comm Med, April 9, 2024 (Posted Apr 10, 2024 8AM)

From the abstract: "We used weekly SARS-CoV-2 wastewater concentration with a stratified random sampling of seroprevalence, and linked vaccination and hospitalization data, from April 2021–August 2021 in Jefferson County, Kentucky (USA). We show the 64% county vaccination rate translate into about a 61% decrease in SARS-CoV-2 incidence. The estimated effect of SARS-CoV-2 Delta variant emergence is a 24-fold increase of infection counts, which correspond to an over 9-fold increase in wastewater concentration. Hospitalization burden and wastewater concentration have the strongest correlation (r?=?0.95) at 1 week lag."

Genomics reveals heterogeneous Plasmodium falciparum transmission and selection signals in Zambia.
Abebe A Fola et al. Commun Med (Lond) 2024 4 (1) 67 (Posted Apr 10, 2024 8AM)

From the abstract: "We conducted genomic surveillance of Plasmodium falciparum parasites from the 2018 Malaria Indicator Survey in Zambia, a nationally representative household survey of children under five years of age. We whole-genome sequenced and analyzed 241?P. falciparum genomes from regions with varying levels of malaria transmission across Zambia and estimated genetic metrics that are informative about transmission intensity, genetic relatedness between parasites, and selection. We provide genomic evidence of widespread within-host polygenomic infections, regardless of epidemiological characteristics, underscoring the extensive and ongoing endemic malaria transmission in Zambia. Our analysis reveals country-level clustering of parasites from Zambia and neighboring regions, with distinct separation in West Africa. "


news Latest News and Publications
A severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nosocomial cluster with inter-facility spread: Lessons learned. External Web Site Icon
Aurora E Pop-Vicas et al. Infect Control Hosp Epidemiol 2024 1 (5) 635-643
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation. External Web Site Icon
Park Seoryeong, et al. Nature communications 2024 0 0. (1) 3368
Are We FLiRTing With A New Covid Wave? External Web Site Icon
(blog post) Topol E. Ground Truths, Apr 18, 2024.
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X. External Web Site Icon
Ben Hu et al. Front Med 2024 4 (1) 1-18
Simultaneous detection and characterization of common respiratory pathogens in wastewater through genomic sequencing. External Web Site Icon
Williams Rachel C, et al. Water research 2024 0 0. 121612
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial. External Web Site Icon
Saraf Amit, et al. Nature medicine 2024 0 0.
Cardiovascular Autonomic Nervous System in a Patient With Hereditary Angioedema Affected by COVID-19. External Web Site Icon
De Maria Beatrice, et al. Cureus 2024 0 0. (3) e56449
Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks. External Web Site Icon
Xu Jiajun, et al. Cell cycle (Georgetown, Tex.) 2024 0 0. 1-30
IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4 T cell responses following COVID-19 mRNA vaccination. External Web Site Icon
Park Hong-Jai, et al. EBioMedicine 2024 0 0. 105114
Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes. External Web Site Icon
Santos-Rebouças Cíntia Barros, et al. Scientific reports 2024 0 0. (1) 8982

More


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP